| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 232.9 | 81.1 |
| Gross profit | 123.3 | 3.9 |
| Profit before tax | 1,071.6 | -143.9 |
| Net income | 1,178.1 | -144.0 |
| EPS (diluted, $ a share) | $0.47 | $-0.45 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +187.1% |
|---|---|
| Gross margin | 52.9% |
| Operating margin | 31.1% |
10-Q filed with the SEC, NASDAQ: CORZ. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Core Scientific, Inc.: key numbers
- Share price
- $13.58Close, Nov 16
- Market cap
- $4.38B
- Shares outstanding
- 322.24MLatest SEC cover page
- Sector
- Crypto Assets
- Industry
- Finance ServicesSIC 6199
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Core Scientific, Inc.
All →Core Scientific Insider Todd M. Duchene Sells $125K of Stock
Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $12.39 to $12.70 a share (average $12.45) in 2 transactions, worth $125K in total on Nov 9, 2026. Shares held after the trade: 1,113,286 (-0.2%).
- Value
- $125K
- Shares
- 10,000
- Average price
- $12.45
- Holding change
- -0.2%
- Trade date
- Nov 9, 2026
Core Scientific Earnings Call: Key Takeaways
Core Scientific is successfully transitioning to a pure-play AI infrastructure provider, leveraging massive contracts with CoreWeave and AMD to drive significant sequential revenue and EBITDA growth despite regulatory and financing headwinds.
- Call
- Nov 5, 2026, 8:30 AM ET
Core Scientific Financial Results
Core Scientific reported third quarter 2026 financial results, highlighted by a nearly 60% sequential increase in colocation revenue to $215.4 million. The company achieved net income of $1.2 billion, primarily driven by a non-cash gain from the change in fair value of warrants, and significantly expanded its Adjusted EBITDA margins to 57%.
“Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue. We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.”
Adam Sullivan, Chief Executive Officer of Core Scientific
Core Scientific Insider Todd M. Duchene Sells $126K of Stock
Todd M. Duchene sold 9,900 shares of Core Scientific, Inc. at $12.78 a share, worth $126K in total on Nov 2, 2026. Shares held after the trade: 1,123,386 (-0.9%).
- Value
- $126K
- Shares
- 9,900
- Price
- $12.78
- Holding change
- -0.9%
- Trade date
- Nov 2, 2026
Core Scientific Insider Todd M. Duchene Sells $136K of Stock
Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $13.27 to $13.80 a share (average $13.56) in 2 transactions, worth $136K in total on Oct 26, 2026. Shares held after the trade: 1,133,286 (-0.5%).
- Value
- $136K
- Shares
- 10,000
- Average price
- $13.56
- Holding change
- -0.5%
- Trade date
- Oct 26, 2026
Core Scientific Insider Todd M. Duchene Sells $139K of Stock
Todd M. Duchene sold 10,000 shares of Core Scientific, Inc. at $13.87 a share, worth $139K in total on Oct 19, 2026. Shares held after the trade: 1,143,286 (-0.9%).
- Value
- $139K
- Shares
- 10,000
- Price
- $13.87
- Holding change
- -0.9%
- Trade date
- Oct 19, 2026